Hippocampal and septal injections of nicotine and 8-OH-DPAT distinguish among different animal tests of anxiety

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 24, Issue 7, 2000, Pages 1053-1067

  Cheeta, Survjit ^a   Kenny, Paul J ^a   File, Sandra E ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

5 HT1A; Anxiety; Dorsal hippocampus; Lateral septum; Nicotine; Panic; Phobia; Serotonin

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; NICOTINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY NEUROSIS; BEHAVIOR; CONTROLLED STUDY; HIPPOCAMPUS; INTRAHIPPOCAMPAL DRUG ADMINISTRATION; INTRASEPTAL DRUG ADMINISTRATION; NEUROBIOLOGY; NONHUMAN; PANIC; RAT; REVIEW; SOCIAL INTERACTION; TRANQUILIZING ACTIVITY;

8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; ANIMALS; ANXIETY DISORDERS; DISEASE MODELS, ANIMAL; HIPPOCAMPUS; MAZE LEARNING; NICOTINE; RATS; SEPTUM OF BRAIN; SEROTONIN AGONISTS;

EID: 0034455553     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0278-5846(00)00129-9     Document Type: Review

References (66)

1. Neuronal nicotinic acetylcholine receptors novel targets for central nervous system therapeutics
2. 1A receptor agonist 8-OH-DPAT
3. 1A-receptors causes amnesia and anxiolytic-like but not antidepressant-like effects in the rat
4. 125i]-L-Bungarotoxin
5. Involvement of the serotonergic system in the hypoactive and antinociceptive effects of nicotine in mice
6. The influence of open arm ledges and maze experience in the elevated plus-maze
7. Can social interaction be used to measure anxiety?
8. The use of social interaction as a method for detecting anxiolytic activity of chlordiazepoxide-like drugs
9. One-trial tolerance to the anxiolytic effects of chlordiazepoxide in the plus- maze
10. Characterisation of the phenomenon of 'one-trial tolerance' to the anxiolytic effect of chlordiazepoxide in the elevated plus-maze
11. Behavioural detection of anxiolytic action
12. The interplay of learning and anxiety in the elevated plus-maze
13. «One-trial tolerance» to the anxiolytic actions of benzodiazepines in the elevated plus-maze, or the development of a phobic state?
14. Trial 2 in the elevated plus-maze: A different form of fear?
15. Raised corticosterone in the rat after exposure to the elevated plus-maze
16. 1A-receptor ligands in dorsal raphé and ventral hippocampus
17. 1A receptor modulation of anxiety in two ethological animal tests
18. Anxiolytic action of neurokinin 1 receptor antagonist in the social interaction test
19. 1 receptors
20. Role of the basolateral nucleus of the amygdala in the formation of a phobia
21. Roles of the dorsal raphe nucleus, lateral septum and the dorsal hippocampus in nicotine's effects on anxiety
22. Role of the dorsomedial hypothalamus in mediating the response to benzodiazepines on trial 2 in the elevated plus- maze test of anxiety
23. Bimodal modulation by nicotine of anxiety in the social interaction test: Role of the dorsal hippocampus
24. The role of the dorsal hippocampal serotonergic and cholinergic systems in the modulation of anxiety
25. The effects of mono-urethanes, di-urethanes and barbiturates on a punishment discrimination
26. The effects of chlordiazepoxide and chlorpromazine on punishment discrimination
27. Simple phobia as a comorbid anxiety disorder
28. 1A and benzodiazepine receptors in the basolateral amygdala modulate anxiety in the social interaction test, but not in the elevated plus-maze
29. A 5-min experience in the elevated plus-maze alters the state of the benzodiazepine receptor in the dorsal raphé nucleus
30. Stimulation of benzodiazepine receptors in the dorsal hippocampus and median raphé reveals differential gabaergic control in two animal tests of anxiety
31. Role of the amygdala and periaqueductal grey in anxiety and panic
32. The elevated T-maze as an experimental model of anxiety
33. Precis of the neuropsychology of anxiety: An inquiry into the functions of the septo-hippocampal system
34. Effects of a-adrenoreceptor agonists and antagonists in a maze-exploration model of "fear motivated" behaviour
35. Lack of habituation of corticosterone in mice repeatedly exposed to the plus-maze
36. Evidence that the amygdala is involved in benzodiazepine and serotonergic effects on punished responding but not on discrimination
37. Time-course of changes in the social interaction test of anxiety following acute and chronic administration of nicotine
38. 1A agonistic anxiolytic
39. 1 receptors
40. Evidence for a dual influence of nicotinic acetylcholine receptors on hippocampal serotonin release
41. Immunocytochemical localization of serotonin(1a) receptors in the rat central-nervous-system
42. Intra-hippocampal buspirone in animal models of anxiety
43. Dorsal hippocampal lesion abolishes the response to FG-7142 in the rat
44. Lateral and medial septal lesions reduce anxiety in the plus-maze and probe-burying tests
45. The septum and the hippocampus differentially mediate anxiolytic effects of R(+)-8-OH-DPAT
46. Effects of centrally administered anxiolytic compounds in animal models of anxiety
47. Modulation of behaviour on trials 1 and 2 in the elevated plus-maze test of anxiety after systemic and hippocampal administration of nicotine
48. Stimulation of nicotinic receptors in the lateral septal nucleus increases anxiety
49. Comparative anatomical distribution of serotonin1A, 1Dα, and 2A receptor mRNAs in human brain postmortem
50. Validation of open: Closed arm entries in an elevated plus-maze as a measure of anxiety in the rat
51. Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: A novel test of anxiety in the rat
52. Excitotoxic lesions of the septum produce anxiolytic effects in the elevated plus-maze and the shock-probe burying tests
53. Serotonin-1A antagonists attenuate the effects of nicotine withdrawal on the auditory startle response
54. Effects of diazepam on behavioural and antinociceptive responses to the elevated plus-maze in male mice depend upon treatment regimen and prior maze experience
55. Influence of prior maze experience on behaviour and response to diazepam in the elevated plus-maze and light/dark tests of anxiety in mice
56. Cholecystokinin and anxiety: Promises and pitfalls
57. 1A receptor agonists
58. Post drug retention of diazepam's effects on habituation to a novel environment in an animal model of anxiety
59. Septal lesions inhibit fear reactions in two animal models of anxiolytic drug action
60. Anxiogenic stimuli in the elevated plus-maze
61. Dissociations among the anxiolytic effects of septal, hippocampal, and amygdaloid lesions
62. Choice of treatment in anxiety
63. A simple and reliable conflict procedure for test anti-anxiety agents